resveratrol
AssetSmall moleculeAlso BIA 6-512
Polyphenolic compound that activates SIRT1 and AMPK, promoting antioxidant defenses and mitochondrial function.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- Indications
- 1
- Trials
- 51
- Developers
- 1
Indications
1Parkinson's disease
Phase 1COMPLETEDNCT03097211clinicaltrials.gov7 Oct 2026
- Targets and what it contains6
- Owner and partners1
- Trials51
- Evidence for its targets7
- Competitors12
- Aging relevance4
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 3 sources